Boehringer Ingelheim Press Releases

Press Release Subscription: Signup here to the Boehringer Ingelheim Newsletter to receive press-releases via email.

Information for...

General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US and UK Journalists Jobseekers

PRESS RELEASE 21 Apr 2020 at 08:00

Aservo® EquiHaler® wins Red Dot for outstanding design quality

Read more on Aservo® EquiHaler® wins Red Dot for outstanding design quality
PRESS RELEASE 14 Apr 2020 at 08:00

2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions

Read more on 2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions
PRESS RELEASE 09 Apr 2020 at 11:00

Boehringer Ingelheim Biopharmaceuticals China receives “Facility of the Year” Award

Read more on Boehringer Ingelheim Biopharmaceuticals China receives “Facility of the Year” Award
PRESS RELEASE 08 Apr 2020 at 10:00

2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic

Read more on 2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic
PRESS RELEASE 08 Apr 2020 at 08:00

Covid Global Support Program

Read more on Covid Global Support Program
PRESS RELEASE 16 Mar 2020 at 09:00

New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib

Read more on New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib
PRESS RELEASE 16 Mar 2020 at 08:00

The World Association for Buiatrics and Boehringer Ingelheim announce the 'Ruminant Well-Being Awards’

Read more on The World Association for Buiatrics and Boehringer Ingelheim announce the 'Ruminant Well-Being Awards’
PRESS RELEASE 28 Feb 2020 at 12:40

Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease

Read more on Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
PRESS RELEASE 27 Feb 2020 at 16:00

Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform

Read more on Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform
PRESS RELEASE 18 Feb 2020 at 15:00

Boehringer Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox

Read more on Boehringer Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox
PRESS RELEASE 17 Feb 2020 at 08:00

Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being

Read more on Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being
PRESS RELEASE 04 Feb 2020 at 07:00

Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy

Read more on Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy
Enleofen

PRESS RELEASE 09 Jan 2020 at 13:00

Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases

Read more on Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases
PRESS RELEASE 03 Jan 2020 at 09:00

Introducing DiaTEC, a new purification technology for Ingelvac CircoFLEX®

Read more on Introducing DiaTEC, a new purification technology for Ingelvac CircoFLEX®
PRESS RELEASE 30 Dec 2019 at 10:30

Milestone for Biopharmaceuticals in China

Read more on Milestone for Biopharmaceuticals in China
PRESS RELEASE 09 Dec 2019 at 09:00

Boehringer Ingelheim announces 2020 BVDzero Case Awards

Read more on Boehringer Ingelheim announces 2020 BVDzero Case Awards
PRESS RELEASE 07 Nov 2019 at 09:00

Boehringer Ingelheim becomes an official partner to CatCareforLife

Read more on Boehringer Ingelheim becomes an official partner to CatCareforLife
PRESS RELEASE 05 Nov 2019 at 09:00

The new African Swine Fever Manual published

Read more on The new African Swine Fever Manual published
KRAS

PRESS RELEASE 29 Oct 2019 at 15:00

Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing

Read more on Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing
PRESS RELEASE 29 Oct 2019 at 11:30

Boehringer Ingelheim joins forces with The Defeat-NCD Partnership to fight non-communicable diseases

Read more on Boehringer Ingelheim joins forces with The Defeat-NCD Partnership to fight non-communicable diseases